|
中文名:氟达拉滨
CAS:21679-14-1
品牌:MedChemExpress (MCE)
存储条件:Powder: -20°C, 3 years; 4°C, 2 years.In solvent: -80°C, 6 months; -20°C, 1 month.
生物活性:Fludarabine (NSC 118218) 是一种 DNA 合成 抑制剂和氟化嘌呤类似物,在淋巴增生性恶性肿瘤中具有抗肿瘤活性。氟达拉滨抑制正常静息或活化淋巴细胞中细胞因子诱导的 STAT1 激活和 STAT1 依赖基因转录[1][2][3][4
体外:Fludarabine(5 μM;48 小时)诱导 p27kip1 表达降低[4]。
体内:氟达拉滨(0.8 mg/kg;ip;两个周期,每 2 周 5 天)与环磷酰胺(400 mg/kg;ip;2 周)联合使用可降低 GVHD 的发生率[5]。
参考文献:[1]. Tournilhac O, et al. Impact of frontline fludarabine and cyclophosphamide combined treatment on peripheral blood stem cell mobilization in B-cell chronic lymphocytic leukemia. Blood. 2004 Jan 1;103(1):363-5. Epub 2003 Sep 11.[2]. Liang YB, et al. Downregulated SOCS1 expression activates the JAK1/STAT1 pathway and promotes polarization of macrophages into M1 type. Mol Med Rep. 2017 Nov;16(5):6405-6411.[3]. Sanhes L, et al. Fludarabine-induced apoptosis of B chronic lymphocytic leukemia cells includes early cleavage of p27kip1 by caspases. Leukemia. 2003 Jun;17(6):1104-11.[4]. Weiss L, et al. Fludarabine in combination with cyclophosphamide decreases incidence of GVHD and maintainseffective graft-versus-leukemia effect after allogeneic stem cell transplantation in murinelymphocytic leukemia. Bone Marrow Transplant. 2003 Jan;31(1):11-5.[5]. Frank DA,et al. Fludarabine-induced immunosuppression is associated with inhibition of STAT1 signaling. Nat Med. 1999 Apr;5(4):444-7.[6]. Frank DA, et al. Fludarabine-induced immunosuppression is associated with inhibition of STAT1 signaling. Nat Med. 1999;5(4):444-447.
Archiver|手机版|科学网 ( 京ICP备07017567号-12 )
GMT+8, 2024-5-20 12:30
Powered by ScienceNet.cn
Copyright © 2007- 中国科学报社